Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different dexamethasone doses for reducing complications after rhinoplasty
IRCT20160307026950N90Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of dexamethasone in postoperative pain, edema, ecchymosis and 1 more (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Facial edema, Ecchymosis and 2 more. Started Oct 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative painedemaecchymosisintraoperative bleeding
Beyond the preview
Go deeper on IRCT20160307026950N90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N90.